Extended use of a selective inhibitor of acid lipase for the diagnosis of Wolman disease and cholesteryl ester storage disease
Authors:
Abstract
No abstract availableKeywords
Funding Information
- CAPES/Brazil
- Propesq/UFRGS
- FIPE/HCPA
- CNPq/INAGEMP (573993/2008-4)
- CNPq/Science Without Borders (313786/2013-5)
This publication has 11 references indexed in Scilit:
- Therapy for Lysosomal Acid Lipase Deficiency: Replacing A Missing LinkHepatology, 2013
- A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2Clinica Chimica Acta, 2012
- Thiadiazole Carbamates: Potent Inhibitors of Lysosomal Acid Lipase and Potential Niemann−Pick Type C Disease TherapeuticsJournal of Medicinal Chemistry, 2010
- Chemical screen to reduce sterol accumulation in Niemann–Pick C disease cells identifies novel lysosomal acid lipase inhibitorsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2009
- Twelve different enzyme assays on dried-blood filter paper samples for detection of patients with selected inherited lysosomal storage diseasesClinica Chimica Acta, 2006
- Wolman disease: Diagnosis by leucocyte acid lipase estimationIndian Journal of Pediatrics, 2005
- Hurler-like PhenotypeClinical Chemistry, 2001
- Use of pyrenemethyl laurate for fluorescence-based determination of lipase activity in intact living lymphoblastoid cells and for the diagnosis of acid lipase deficiencyBiochemical Journal, 1993
- New spectrophotometric assays of acid lipase and their use in the diagnosis of wolman and cholesteryl ester storage diseasesAnalytical Biochemistry, 1985
- Acid esterase activity in cultured skin fibroblasts and amniotic fluid cells using 4-methylumbelliferyl palmitateClinica Chimica Acta, 1978